Ovid Therapeutics (OVID) Return on Capital Employed Growth (3y) (2020 - 2026)
Ovid Therapeutics (OVID) Return on Capital Employed Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -356.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -516.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -2,309.00 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4,967.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,424.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 513.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5,777.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 109.00 |
| 10 | Ovid Therapeutics | 385.37 Mn | 229.84 Mn | - | 1,032.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,032.00 |
| Dec 31, 2025 | -655.00 |
| Dec 31, 2024 | -13,799.00 |
| Sep 30, 2024 | -13,393.00 |
| Jun 30, 2024 | -11,895.00 |
| Mar 31, 2024 | -13,018.00 |
| Dec 31, 2023 | 8,381.00 |
| Sep 30, 2023 | 10,896.00 |
| Jun 30, 2023 | 15,720.00 |
| Mar 31, 2023 | 7,238.00 |
| Dec 31, 2022 | 8,597.00 |
| Dec 31, 2021 | 18,396.00 |
| Sep 30, 2021 | 15,775.00 |
| Jun 30, 2021 | 12,861.00 |
| Mar 31, 2021 | 13,925.00 |
| Dec 31, 2020 | -5,768.00 |
| Sep 30, 2020 | -8,994.00 |
| Jun 30, 2020 | -11,672.00 |
| Mar 31, 2020 | 694.00 |